Latest News

  • Real-time Molecule Monitoring Could Put an End to ‘Reactive Medicine’

    Diagnostics World | Modern jet engines can generate a terabyte or more of data per hour that gets transmitted back to the engine manufacturer to ensure aircraft safety and prevent disasters from happening. Yet the human body, arguably the most important machinery of them all, gets checked only once a year or whenever something has already gone wrong.

    Jun 17, 2025

  • Myeloma Diagnostics: Ultra-Sensitive Detection and Population-Scale Screening Transform Disease Management

    Diagnostics World | The International Myeloma Foundation's Black Swan Research Initiative is changing how multiple myeloma is detected, monitored, and managed. From single-cell detection technologies to population-scale screening programs, these advances are setting new standards for precision oncology diagnostics.

    Jun 12, 2025

  • Pharmacogenomic Testing Shows Value in Improving Prescribing Precision

    Diagnostics World | After the human genome was sequenced in 2003, expectations were high that it would drive direct and immediate benefits for the everyday healthcare of the general population. While genomics has fundamentally altered the clinical pathways for individuals with rare diseases and cancer, it has yet to become part of routine clinical practice.

    Jun 11, 2025

  • Endometriosis Developments: Newly Launched Tests and Treatment Updates

    Diagnostics World | Endometriosis occurs when tissue similar to the lining of the uterus grows outside of the uterus. The condition is painful, can impede fertility, and is difficult to diagnose. But a host of new tools seek to improve diagnostics and treatment for the condition.

    Jun 10, 2025

  • Genetic Diagnostics Find Common Ground Between ME/CFS, Long COVID

    Diagnostics World | PrecisionLife's new diagnostic approach is addressing a critical gap in complex chronic disease detection by targeting two genetically related conditions that share remarkable similarities. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are not just clinically similar—they're genetically connected, with researchers identifying nine genes common to both disease populations.

    Jun 5, 2025

  • After More Than Four Decades, a Third Subtype of Castleman Disease Found

    Diagnostics World | A new subtype of Castleman disease has been identified, the first such major discovery in 45 years. While it remains unclear how many individuals stand to benefit, this is a “hugely important” development for the proportion of patients who fit neither the “unicentric” nor “multicentric” criteria long used to describe the symptoms and disease experience.

    Jun 3, 2025

  • Follow the Money: Deepull’s Diagnostic System, Gestalt Expands Pathology Platform, More

    Diagnostics World | iCAD announced a collaboration with Microsoft to include a set of AI-powered mammography solutions; Revvity has launched its new IDS i20 analytical random access platform from EUROIMMUN; and more.

    May 30, 2025

  • Microsoft, iCAD Collaboration, Revvity Launches New Platform, More

    Diagnostics World | iCAD announced a collaboration with Microsoft to include a set of AI-powered mammography solutions; Revvity has launched its new IDS i20 analytical random access platform from EUROIMMUN; and more.

    May 29, 2025